Midmark to open technology center for consumer and industry researchNovember 8, 2018A research and development hub open to customers, industry leaders, and partners from around the world is Midmark Corp.’s newest step toward its evolution as a clinical environmental design company.
SPONSORED CONTENTThe clear reco for hidden stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More
Nutrition's role in cancer patientsNovember 5, 2018Nutrition is always important in helping a sick pet get better, and it can be an essential element of care for cancer patients and for pets recovering from debilitating illnesses or surgery. Cancer and its treatments may alter the body’s ability to tolerate particular foods or use certain nutrients; moreover, clients often have a firm belief in nutrition as good medicine and may ask about or even insist on special diets or supplements for pets undergoing cancer treatments or otherwise in need of tender loving care.
Stem cell treatments hold promise, require more researchOctober 24, 2018Over the past several years, some companies have produced various stem cell products for treating a variety of equine conditions, including tendon and ligament injuries, laminitis, and ocular issues, to name a few. There’s no question stem cells carry tremendous promise for the treatment of many diseases and injuries.
Maddie's Fund grants $2.8M to aid access to veterinary careJuly 31, 2018Millions of pets across the United States and their owners will soon have access to affordable veterinary care, thanks to a $2.8-million donation from Maddie’s Fund.
Is a cure for IMHA near?May 3, 2018The image of a straight line neatly sums up the frustration of treating dogs afflicted with immune-mediated hemolytic anemia (IMHA), according to Andrew Mackin, BVMS, DVSc, FANZCVSc, DACVIM, professor and head of the Department of Clinical Sciences at Mississippi State University College of Veterinary Medicine.
Information overload means good newsDecember 8, 2017Let’s face it; we can’t even keep up with all the email, client communications, and news flashing on our smartphones while maintaining a busy clinical load. Once-a-year continuing education barely keeps us afloat in the ocean of veterinary information, and now that information—thanks to accelerating advancements in technology and biological research—is coming at us more and more rapidly and in more forms.
Winn Feline Foundation: Funding five decades of feline healthNovember 10, 2017If you’ve never treated a cat for dilated cardiomyopathy (DCM), thank the Winn Feline Foundation. If you’ve ever vaccinated a cat for feline leukemia, thank Winn. If you’ve adjusted a diabetic cat’s diet by adding protein and simultaneously creating a weight loss plan that sent the cat into remission, thank Winn.
AKC Canine Health Foundation funds clinical trial to study cannabidiol in treating drug-resistant epilepsy in dogsSeptember 14, 2017By Veterinary Practice News Editors The AKC Canine Health Foundation (CHF), which has funded more than $2 million for canine epilepsy research, launched an initiative in 2017 to further understand the most common neurological disorder that affects pure- and mixed-breed dogs. Improved treatments are urgently needed, especially for dogs with drug-resistant epilepsy or where side effects of currently available drugs are not tolerated, according to the organization. To that, the CHF has announced the beginning a major clinical trial to study the use of cannabidiol to treat drug resistant epilepsy in dogs. Stephanie McGrath, MS, DVM, DACVIM (Neurology), at Colorado State University's College of Veterinary Medicine and Biomedical Sciences, will lead "Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy." According to Dr. McGrath, up to 30 percent of dogs receiving standard anti-epileptic therapy remain uncontrolled for their seizures, and the side effects of the antiepileptic drugs are often unacceptable. CBD, a nonpsychotropic component of the Cannabis sativa plant, has been shown to have anticonvulsant properties; this randomized, double-blinded, placebo-controlled, crossover clinical trial study will be utilized to prove its effectiveness, she stated. "The timeliness and importance of research into the role of cannabis in …
Likarda receives $4M to expand companion animal diabetes researchSeptember 4, 2017Likarda, a regenerative medicine company for companion animals, has received $4 million in Series A funding from Werth Family Investment Associates to back the company's proprietary Kanslet insulin-producing cell clusters, which can be infused into animals with diabetes, allowing veterinarians to offer a minimally invasive and cost-effective answer to pet owners, according to the company. Microencapsulated islets (the insulin-producing cells of the body) are transplanted via injection into the belly of a diabetic dog, removing the need for twice-daily insulin injections, the company stated. The additional funding allows Likarda to scale the project to thousands of animals, and the clinical research program is expected to launch by the end of 2017. "Partnership with Werth Family Investment Associates brings both funds to advance our product line and extensive experience in successful pharmaceutical licensing of new products for both human and animal health," said Lisa Stehno-Bittel, Ph.D., Likarda president and co-founder. "[It's] exciting and transformational for both animal health in the region and the global prospect of cell-based therapies for diabetic pets."
How bioinformatics research could affect veterinary practices, companion animal healthAugust 30, 2017Let’s face it; we can’t even keep up with all the email, client communications, and news flashing on our smartphones while maintaining a busy clinical load. Once-a-year continuing education barely keeps us afloat in the ocean of veterinary information, and now that information is coming at us more and more rapidly and in more forms.
